Sideroblastic Anemia

Sideroblastic anemia is a type of blood disorder that affects the body's ability to produce healthy red blood cells. It involves the bone marrow, where blood cells are made, and specifically disrupts the production of hemoglobin, the protein that carries oxygen in red blood cells. This condition causes the body to produce abnormal red blood cells called sideroblasts, which have iron-loaded mitochondria visible under a microscope. As a result, people with this anemia often experience symptoms like fatigue, weakness, and pale skin due to reduced oxygen delivery to tissues. The disorder can be inherited or acquired and may be linked to other health problems affecting blood or metabolism.

Sideroblastic anemia is a heterogeneous group of disorders characterized by defective incorporation of iron into heme during erythropoiesis, leading to the accumulation of iron-laden mitochondria around the nucleus of erythroblasts, known as ring sideroblasts. The core pathology involves impaired activity of enzymes such as ALA synthase or defects in mitochondrial metabolism, often due to mutations in genes like ALAS2 or acquired causes such as myelodysplastic syndromes or toxin exposure. This results in ineffective erythropoiesis and microcytic or normocytic anemia with systemic iron overload. Clinically, it is significant because it can cause chronic anemia, iron toxicity, and may progress to marrow failure or leukemia in some cases. Diagnosis and management require understanding the underlying etiology and distinguishing it from other causes of anemia.